Gary J. Pruden is a Director and a member of the Audit Committee and the Financing and Strategy Committee, serving on the Board of Directors since February 2018.  Most recently, Mr. Pruden held a number of senior commercial leadership positions across both the medical device and pharmaceutical sectors of Johnson & Johnson (“J&J”) from 1985 until 2017.  In April 2016, Mr. Pruden was appointed as a member of the Executive Committee of J&J, where his official title was Executive Vice President, Worldwide Chairman, Medical Devices.  Prior to that, he held roles of increasing responsibility within J&J, serving as Worldwide Chairman in the Medical Devices division from 2015 to 2016, as Worldwide Chairman of Global Surgery Group from 2012 to 2015, as Company Group Chairman of Ethicon, Inc. from 2009 to 2012, as Worldwide President of Ethicon, Inc., a J&J subsidiary, from 2006 to 2009, and as President of the J&J subsidiary, Janssen-Ortho Inc. in Canada, from 2004 to 2006.  Mr. Pruden has also served in several capacities, including Chairman of Technology & Regulatory Committee and Executive Committee Member with the Advanced Medical Technology Association, a medical device trade association.  Mr. Pruden currently serves on the Board of Directors of Motus GI Holdings, Inc.  Mr. Pruden received his Bachelor of Science in Finance at Rider University, where he later served on the Board of Trustees from 2011 until 2015.